✦ LIBER ✦

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the assessment of the safety of a new thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

✍ Scribed by Peter R Sinnaeve; John H Alexander; Kris Bogaerts; Ann Belmans; Lars Wallentin; Paul Armstrong; Jennifer A.A Adgey; Michal Tendera; Rafael Diaz; Leopoldo Soares-Piegas; Alec Vahanian; Christopher B Granger; Frans J Van De Werf

Book ID: 116189519
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 147
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2003.12.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The assessment of the safety and efficac

The assessment of the safety and efficacy of a new thrombolytic regimen (assent)-3 investigators. efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the assent-3 randomized trial in acute myocardial infarction

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 116 KB

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT) 3 plus randomized trial in acute myocardial infarction

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and safety of two unfractionate

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)

✍ Jeptha P Curtis; John H Alexander; Yao Huang; Lars Wallentin; Freek W.A Verheugt 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Unraveling the spectrum of left bundle b

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

✍ Hussam Al-Faleh; Yuling Fu; Galen Wagner; Shaun Goodman; Elena Sgarbossa; Christ 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

One-year follow-up of the ASSENT-2 trial

One-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction

✍ Peter Sinnaeve; John Alexander; Ann Belmans; Kris Bogaerts; Anatoli Langer; Rafa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB